Macquarie Group’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-400
Closed -$13K 1840
2022
Q3
$13K Sell
400
-448
-53% -$10.1K ﹤0.01% 2310
2022
Q2
$21K Hold
848
﹤0.01% 2289
2022
Q1
$31 Hold
848
﹤0.01% 2289
2021
Q4
$65K Hold
848
﹤0.01% 2073
2021
Q3
$82K Buy
848
+217
+34% +$23.7K ﹤0.01% 2045
2021
Q2
$67K Sell
631
-253
-29% -$24.9K ﹤0.01% 2098
2021
Q1
$79K Sell
884
-944
-52% -$104K ﹤0.01% 1966
2020
Q4
$184K Buy
1,828
+400
+28% +$29.8K ﹤0.01% 1687
2020
Q3
$70K Hold
1,428
﹤0.01% 1869
2020
Q2
$58K Buy
+1,428
New +$41K ﹤0.01% 1893
2020
Q1
Sell
-17,335
Closed -$393K 1972
2019
Q4
$393K Buy
+17,335
New +$284K ﹤0.01% 1446

Other funds holding CRNC

Macquarie Group's CRNC Position: Q4 2022 in Review

Macquarie Group sold out of Cerence (CRNC) in Q4 2022, closing a stake of 400 shares — an estimated $13K sold.

Macquarie Group first reported a position in CRNC in Q4 2019 and held it in 11 quarters. The position peaked at $393K in Q4 2019. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.

  • Macquarie Group reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 400 Cerence shares in Q4 2022, an estimated $13K.
  • Macquarie Group first reported a position in Cerence in Q4 2019 and held it in 11 quarters.
  • Macquarie Group's Cerence position peaked at $393K in Q4 2019.
  • 223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.